Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 21 | 2025 | 1413 | 2.400 |
Why?
|
| Diabetes Mellitus, Type 1 | 12 | 2025 | 873 | 1.320 |
Why?
|
| Insulin Resistance | 6 | 2025 | 699 | 0.970 |
Why?
|
| Hypoglycemic Agents | 13 | 2025 | 481 | 0.960 |
Why?
|
| Lipoproteins | 1 | 2025 | 191 | 0.830 |
Why?
|
| Hypoglycemia | 5 | 2025 | 192 | 0.800 |
Why?
|
| Blood Glucose | 16 | 2025 | 1170 | 0.700 |
Why?
|
| Metformin | 4 | 2020 | 165 | 0.670 |
Why?
|
| Hyperglycemia | 4 | 2022 | 240 | 0.590 |
Why?
|
| Atherosclerosis | 1 | 2025 | 996 | 0.520 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 656 | 0.450 |
Why?
|
| Adolescent | 28 | 2025 | 20607 | 0.440 |
Why?
|
| Insulin | 7 | 2022 | 1226 | 0.420 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 673 | 0.270 |
Why?
|
| Depression | 5 | 2025 | 1352 | 0.240 |
Why?
|
| Automobile Driving | 1 | 2025 | 34 | 0.220 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2025 | 82 | 0.220 |
Why?
|
| Affect | 1 | 2025 | 173 | 0.220 |
Why?
|
| Peer Group | 1 | 2024 | 122 | 0.210 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 188 | 0.200 |
Why?
|
| Humans | 36 | 2025 | 133242 | 0.200 |
Why?
|
| Mentors | 1 | 2024 | 164 | 0.200 |
Why?
|
| Young Adult | 8 | 2025 | 9976 | 0.190 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 119 | 0.190 |
Why?
|
| Medication Adherence | 3 | 2020 | 327 | 0.190 |
Why?
|
| Quality of Life | 3 | 2024 | 2159 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 300 | 0.180 |
Why?
|
| Male | 23 | 2025 | 65435 | 0.180 |
Why?
|
| Female | 24 | 2025 | 71474 | 0.170 |
Why?
|
| Puberty | 1 | 2021 | 104 | 0.170 |
Why?
|
| Self Report | 1 | 2024 | 553 | 0.170 |
Why?
|
| Sleep | 1 | 2024 | 369 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 108 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1504 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 480 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2025 | 577 | 0.160 |
Why?
|
| Vaccination | 1 | 2025 | 1019 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 902 | 0.160 |
Why?
|
| Child | 18 | 2022 | 25900 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2020 | 123 | 0.150 |
Why?
|
| Age of Onset | 1 | 2020 | 626 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 148 | 0.150 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 16 | 0.140 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2025 | 124 | 0.140 |
Why?
|
| Medicaid | 1 | 2020 | 245 | 0.140 |
Why?
|
| Self Care | 3 | 2024 | 228 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 113 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2020 | 5176 | 0.120 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 314 | 0.120 |
Why?
|
| Glucagon | 1 | 2016 | 174 | 0.120 |
Why?
|
| Insulin Infusion Systems | 3 | 2022 | 66 | 0.120 |
Why?
|
| Adult | 9 | 2025 | 31746 | 0.120 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 67 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2025 | 1464 | 0.110 |
Why?
|
| Biomarkers | 2 | 2024 | 3411 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 917 | 0.110 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 19 | 0.110 |
Why?
|
| Family | 2 | 2009 | 596 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 71 | 0.100 |
Why?
|
| Risk Factors | 6 | 2024 | 10938 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 818 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 365 | 0.090 |
Why?
|
| Heart Atria | 1 | 2014 | 334 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 1714 | 0.080 |
Why?
|
| Cysteine | 1 | 2010 | 143 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 172 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 198 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2023 | 462 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 786 | 0.080 |
Why?
|
| Glucose | 2 | 2023 | 914 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2011 | 475 | 0.070 |
Why?
|
| Parents | 1 | 2015 | 1076 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 214 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 22 | 0.070 |
Why?
|
| Obesity | 3 | 2015 | 2419 | 0.070 |
Why?
|
| United States | 2 | 2020 | 11659 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 2066 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 253 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 48 | 0.060 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 51 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 59 | 0.060 |
Why?
|
| Health Promotion | 1 | 2007 | 404 | 0.050 |
Why?
|
| Health Behavior | 1 | 2007 | 400 | 0.050 |
Why?
|
| Social Support | 1 | 2005 | 388 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2024 | 200 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 64 | 0.050 |
Why?
|
| Exercise | 1 | 2007 | 867 | 0.040 |
Why?
|
| Time Factors | 2 | 2024 | 6527 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 178 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3095 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2022 | 14917 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1169 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5449 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 240 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6579 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 50 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 85 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 712 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 256 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2022 | 996 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 349 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 414 | 0.030 |
Why?
|
| Androgens | 1 | 2018 | 296 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 130 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 557 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2015 | 4 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 2671 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 457 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 437 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1169 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 541 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 229 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 25 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 29 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 112 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 907 | 0.020 |
Why?
|
| Testosterone | 1 | 2018 | 620 | 0.020 |
Why?
|
| Survival Rate | 1 | 2017 | 2199 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1704 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2247 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 2950 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2161 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 21 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 1023 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17503 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 5043 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 27 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2010 | 81 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 49 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 253 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 210 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 142 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 196 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 1129 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 309 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 280 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1355 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 47 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 170 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 86 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 13072 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 484 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 233 | 0.020 |
Why?
|
| Texas | 2 | 2007 | 3658 | 0.020 |
Why?
|
| Community Health Services | 1 | 2007 | 93 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 101 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 29026 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 79 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2007 | 71 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1348 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2009 | 396 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 119 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 56 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 257 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 244 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 232 | 0.010 |
Why?
|
| Minority Groups | 1 | 2007 | 248 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2007 | 457 | 0.010 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 425 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 823 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2006 | 306 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2003 | 51 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 1034 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 694 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2010 | 893 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21486 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 191 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 1311 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1085 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 858 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1849 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3171 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1973 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 3990 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 7593 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8635 | 0.010 |
Why?
|